Musk startup Neuralink says it's been cleared to test brain implants in humans
CBSN
Elon Musk's start-up Neuralink on Thursday said it has approval from U.S. regulators to test its brain implants in people.
Neuralink said clearance from the Food and Drug Administration for its first in-human clinical study is "an important first step" for its technology, which is intended to enable brains to interface directly with computers.
"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter.
Microsoft is pulling the plug on Skype, the pioneering Internet telecommunications and video call platform it bought nearly 14 years ago for $8.5 billion.
Measles cases popping up across the United States, including an outbreak in Texas that has led to the death of a child, are prompting questions about where exactly the illness has been detected.